Tectonic Therapeutic, Inc. (TECX) Financial Statements
Free cash flow over the same period: -$72.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TECXTectonic Therapeutic, Inc.Follow TECX — free
—
Price chart with a free account
- Market cap
- 392.4M
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Research & development | 35.1 | 55.0 | 87.2 | 83.1 | 72.2 | 37.0 | 41.4 | 63.5 | 72.2 | |
| Operating income | -46.2 | -75.8 | -120.2 | -118.8 | -105.4 | -44.6 | -58.0 | -84.0 | -94.9 | |
| Pre-tax income | -46.4 | -73.0 | -119.7 | -119.1 | -105.9 | -42.8 | -58.0 | -72.9 | -85.5 | |
| Income tax | — | — | — | — | — | 0.0 | 0.0 | 1.2 | 0.3 | |
| Net income | -46.4 | -73.0 | -119.7 | -119.1 | -105.9 | -42.8 | -58.0 | -74.2 | -85.8 | |
| Diluted EPS ($) | -3.62 | -2.66 | -3.31 | -2.78 | -2.42 | -33.76 | -6.83 | -4.05 | -4.57 | |
| Diluted shares (mn) | — | — | — | — | 43.7 | 1.3 | 8.5 | 18.3 | — |
USD millions · SEC XBRL
Tectonic Therapeutic, Inc. — questions
- What is Tectonic Therapeutic, Inc.'s net income?
- -$85.8M over the twelve months to 2026-06-30.
- What is Tectonic Therapeutic, Inc.'s free cash flow?
- -$72.4M over the twelve months to 2026-06-30.
- What are Tectonic Therapeutic, Inc.'s diluted earnings per share?
- $-4.57 over the twelve months to 2026-06-30.
Every figure on this page comes from Tectonic Therapeutic, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.